Dr. Nakhla is a distinguished academic and pharmacist specializing in minor ailments, non-prescription therapeutics, and patient self-care, with over fifteen years of dedicated commitment in these crucial areas. Her expertise has garnered recognition at provincial, national, and international levels, where she has presented on these subjects and authored chapters in esteemed pharmacy education textbooks. She has been honoured with prestigious awards, including the Pfizer Bowl of Hygeia Award in 2020 and the Distinguished Teaching Award in 2023.
As an early career researcher, Dr. Nakhla spearheaded a study assessing the quality and quantity of self-care and minor ailment education across Canadian pharmacy schools. Currently, Dr. Nakhla's research is centered on evaluating the impact of minor ailment prescribing by pharmacists on patient and health system outcomes, alongside assessing the implications of Rx-to-OTC switches on patient health.
With a robust background in pharmacist and student pharmacist education innovation and advocacy for regulatory reforms, Dr. Nakhla has played a significant role in advancing pharmacy practice. Serving as the CEO and co-founder of MAPflow, a cutting-edge clinical decision-support tool tailored for minor ailment assessment and prescribing services, Dr. Nakhla is at the forefront of driving innovation in the field, all while remaining steadfast in her commitment to empowering pharmacists and effecting tangible change in healthcare delivery.
Dr. Nakhla is a distinguished academic and pharmacist specializing in minor ailments, non-prescription therapeutics, and patient self-care, with over fifteen years of dedicated commitment in these crucial areas. Her expertise has garnered recognition at provincial, national, and international levels, where she has presented on these subjects and authored chapters in esteemed pharmacy education textbooks. She has been honoured with prestigious awards, including the Pfizer Bowl of Hygeia Award in 2020 and the Distinguished Teaching Award in 2023.
As an early career researcher, Dr. Nakhla spearheaded a study assessing the quality and quantity of self-care and minor ailment education across Canadian pharmacy schools. Currently, Dr. Nakhla's research is centered on evaluating the impact of minor ailment prescribing by pharmacists on patient and health system outcomes, alongside assessing the implications of Rx-to-OTC switches on patient health.
With a robust background in pharmacist and student pharmacist education innovation and advocacy for regulatory reforms, Dr. Nakhla has played a significant role in advancing pharmacy practice. Serving as the CEO and co-founder of MAPflow, a cutting-edge clinical decision-support tool tailored for minor ailment assessment and prescribing services, Dr. Nakhla is at the forefront of driving innovation in the field, all while remaining steadfast in her commitment to empowering pharmacists and effecting tangible change in healthcare delivery.